Publications by Dr Jennifer Munkley - ePrints

Browsing publications by Dr Jennifer Munkley.

Newcastle Authors	Title	Year
Chile Siachisumo Dr Sara Luzzi Saad Aldalaqan Dr Gerald Hysenaj Caroline Dalgliesh et al.	An anciently diverged family of RNA binding proteins maintain correct splicing of a class of ultra-long exons through cryptic splice site repression	2024
Dr Kirsty Hodgson Maggie Orozco Moreno Emily Archer Goode Dr Rebecca Garnham Karen Livermore et al.	Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone	2024
Maggie Orozco Moreno Dr Kirsty Hodgson Amirah Nabilah Meera Murali Jess Peng et al.	Sialylation Inhibition Can Partially Revert Acquired Resistance to Enzalutamide in Prostate Cancer Cells	2024
Rebecca Garnham Dr Daniel Geh Ryan Nelson Erik Ramon Gil Laura Wilson et al.	ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer	2024
Rahul Advani Dr Sara Luzzi Dr Emma Scott Caroline Dalgliesh Dr Jennifer Munkley et al.	Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer	2023
Rebecca Garnham Dr Daniel Geh Ryan Nelson Erik Ramon Gil Laura Wilson et al.	ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer	2023
Dr Emma Scott Emily Archer Goode Rebecca Garnham Dr Kirsty Hodgson Maggie Orozco Moreno et al.	ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression	2023
Maggie Orozco Moreno Dr Kirsty Hodgson Kayla Bastian Emily Archer Goode Dr Jennifer Munkley et al.	Targeting aberrant sialylation and fucosylation in prostate cancer cells using potent metabolic inhibitors	2023
Dr Kirsty Hodgson Maggie Orozco Moreno Dr Emma Scott Rebecca Garnham Karen Livermore et al.	The role of GCNT1 mediated O-glycosylation in aggressive prostate cancer	2023
Dr Emma Scott Dr Kirsty Hodgson Kat Cheung Edward Yo Laura Wilson et al.	Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth	2023
Dr Jennifer Munkley	Aberrant Sialylation in Cancer: Therapeutic Opportunities	2022
Adam Duxfield Dr Jennifer Munkley Professor Michael Briggs Dr Ella Dennis	CRELD2 is a novel modulator of calcium release and calcineurin-NFAT signalling during osteoclast differentiation	2022
Dr Emma Scott Rebecca Garnham Adam Duxfield Professor David Elliott Dr Jennifer Munkley et al.	Pro-Survival Factor EDEM3 Confers Therapy Resistance in Prostate Cancer	2022
Kayla Bastian Dr Emma Scott Professor David Elliott Dr Jennifer Munkley	Fut8 alpha-(1,6)-fucosyltransferase in cancer	2021
Dr Emma Scott Professor David Elliott Dr Jennifer Munkley	Tumour associated glycans: A route to boost immunotherapy?	2020
Alice Coomer Dr Fiona Black Professor Alastair Greystoke Dr Jennifer Munkley Professor David Elliott et al.	Alternative splicing in lung cancer	2019
Dr Jennifer Munkley SR Gokul Krishnan Gerald Hysenaj Dr Emma Scott Caroline Dalgliesh et al.	Androgen-regulated transcription of ESRP2 drives alternative splicing patterns in prostate cancer	2019
Emma Scott Dr Jennifer Munkley	Glycans as Biomarkers in Prostate Cancer	2019
Rebecca Garnham Dr Emma Scott Karen Livermore Dr Jennifer Munkley	ST6GAL1: A key player in cancer (Review)	2019
Dr Jennifer Munkley Dr Emma Scott	Targeting Aberrant Sialylation to Treat Cancer	2019
Dr Jennifer Munkley	The glycosylation landscape of pancreatic cancer	2019
Dr Jennifer Munkley Karen Livermore Dr Ingrid Ehrmann Dr Katherine James Dr Prabhakar Rajan et al.	Androgen-dependent alternative mRNA isoform expression in prostate cancer cells	2018
Dr Jennifer Munkley	Glycosylation is a global target for androgen control in prostate cancer cells	2017
Dr Jennifer Munkley Karen Livermore Dr Prabhakar Rajan Professor David Elliott	RNA splicing and splicing regulator changes in prostate cancer pathology	2017
Dr Jennifer Munkley Dr Urszula McClurg Karen Livermore Dr Ingrid Ehrmann Professor Craig Robson et al.	The cancer-associated cell migration protein TSPAN1 is under control of androgens and its upregulation increases prostate cancer cell migration	2017
Karen Livermore Dr Jennifer Munkley Professor David Elliott	Androgen receptor in prostate cancer	2016
Dr Jennifer Munkley Karen Livermore Dr Katherine James Dr Brian Wilson Professor Craig Robson et al.	Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability	2016
Dr Jennifer Munkley Professor David Elliott	Hallmarks of glycosylation in cancer	2016
Dr Irina Neganova Dr Evgeniya Shmeleva Dr Jennifer Munkley Dr Valeria Chichagova Dr George Anyfantis et al.	JNK/SAPK signalling is essential for efficient reprogramming of human fibroblasts to induced pluripotent stem cells	2016
Dr Jennifer Munkley Professor David Elliott	Sugars and cell adhesion: the role of ST6GalNAc1 in prostate cancer progression	2016
Dr Jennifer Munkley Professor David Elliott	The role of glycans in the development and progression of prostate cancer	2016
Dr Jennifer Munkley	The Role of Sialyl-Tn in Cancer	2016
Dr Jennifer Munkley Professor Craig Robson Professor Hing Leung Dr Prabhakar Rajan Professor David Elliott et al.	Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer	2015
Dr Brian Wilson Dr Jennifer Munkley	Metronidazole Toxicity in Cockayne Syndrome: A Case Series	2015
Dr Jennifer Munkley Dr Brian Wilson Karen Livermore Dr Vasileios Floros Professor Craig Robson et al.	The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer	2015
Dr Jennifer Munkley Karen Livermore Dr Urszula McClurg Professor Craig Robson Dr Prabhakar Rajan et al.	The PI3K regulatory subunit gene PIK3R1 is under direct control of androgens and repressed in prostate cancer cells	2015
Dr Veronika Boczonadi Dr Juliane Mueller Dr Angela Pyle Dr Jennifer Munkley Michele Giunta et al.	EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia	2014
Dr Jennifer Munkley Dr Prabhakar Rajan Caroline Dalgliesh Robert Jackson Professor Craig Robson et al.	A novel androgen-regulated isoform of the TSC2 tumour suppressor gene increases cell proliferation	2014